968 related articles for article (PubMed ID: 9276127)
1. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
[TBL] [Abstract][Full Text] [Related]
2. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
[TBL] [Abstract][Full Text] [Related]
3. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
Meini S; Patacchini R; Maggi CA
Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
[TBL] [Abstract][Full Text] [Related]
4. NK1 and NK2 receptors mediate tachykinin and resiniferatoxin-induced bronchospasm in guinea pigs.
Foulon DM; Champion E; Masson P; Rodger IW; Jones TR
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):915-21. PubMed ID: 7692776
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G
Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
7. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
8. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
9. Mediation of irregular spiking activity by multiple neurokinin-receptors in the small intestine of the rat.
Lördal M; Bränström R; Hellström PM
Br J Pharmacol; 1998 Jan; 123(1):63-70. PubMed ID: 9484855
[TBL] [Abstract][Full Text] [Related]
10. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
Patacchini R; Barthó L; Maggi CA
Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
[TBL] [Abstract][Full Text] [Related]
11. Neurokinin A-induced vasoconstriction and muscular contraction in the rat isolated stomach: mediation by distinct and unusual neurokinin2 receptors.
Lippe I; Wachter CH; Holzer P
J Pharmacol Exp Ther; 1997 Jun; 281(3):1294-302. PubMed ID: 9190865
[TBL] [Abstract][Full Text] [Related]
12. Role of NK1 and NK2 receptors in mouse gastric mechanical activity.
Mulè F; Amato A; Vannucchi MG; Faussone-Pellegrini MS; Serio R
Br J Pharmacol; 2006 Feb; 147(4):430-6. PubMed ID: 16402037
[TBL] [Abstract][Full Text] [Related]
13. In vivo effects of neurokinin B on rat urinary bladder motility: involvement of tachykinin NK1 and NK2 receptors.
Lecci A; Giuliani S; Meini S; Maggi CA
Neuropeptides; 1994 Jul; 27(1):53-62. PubMed ID: 7969819
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of tachykinin NK2 receptors on isolated human urinary bladder, prostatic urethra and prostate.
Palea S; Corsi M; Artibani W; Ostardo E; Pietra C
J Pharmacol Exp Ther; 1996 May; 277(2):700-5. PubMed ID: 8627548
[TBL] [Abstract][Full Text] [Related]
16. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
17. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
18. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
[TBL] [Abstract][Full Text] [Related]
19. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor.
Figini M; Emanueli C; Bertrand C; Javdan P; Geppetti P
Br J Pharmacol; 1996 Mar; 117(6):1270-6. PubMed ID: 8882625
[TBL] [Abstract][Full Text] [Related]
20. The rabbit iris sphincter contains NK1 and NK3 but not NK2 receptors: a study with selective agonists and antagonists.
Wang ZY; Håkanson R
Regul Pept; 1993 Apr; 44(3):269-75. PubMed ID: 7683436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]